2. International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. Lyon: International Agency for Research on Cancer;cited 2015 Apr 9. Available from:
http://globocan.iarc.fr.
3. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46:109–123.
Article
4. Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010; 200:454–461.
Article
5. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev. 2011; 12:1657–1663.
6. National Evidence-based Healthcare Collaborating Agency. A research on evidence-based healthcare for thyroid cancer screening. Seoul: National Evidence-based Healthcare Collabo-rating Agency;2012.
7. Choi YJ, Park YL, Koh JH. Prevalence of thyroid cancer at a medical screening center: pathological features of screen-detected thyroid carcinomas. Yonsei Med J. 2008; 49:748–756.
Article
8. Chung WY, Chang HS, Kim EK, Park CS. Ultrasonographic mass screening for thyroid carcinoma: a study in women scheduled to undergo a breast examination. Surg Today. 2001; 31:763–767.
Article
9. Yamada H, Katoh A, Ishinaga H. Ultrasonographic screening for thyroid cancer in the screening. Nihon Jibiinkoka Gakkai Kaiho. 2000; 103:13–18.
Article
10. Han YM, Lim SM, Choi HY, Kim Y. Value of ultrasonographic mass screening for thyroid carcinoma in patients undergoing a breast ultrasonography. J Korean Soc Ultrasound Med. 2005; 24:75–80.
11. Lee YS, Nam KH, Chung WY, Chang HS, Park CS. Postoperative complications of thyroid cancer in a single center experience. J Korean Med Sci. 2010; 25:541–545.
Article
12. Jung YM, Kim JS, Park JS. Recurrence and complications from the surgical procedure for treating a papillary thyroid carcinoma. J Korean Surg Soc. 2001; 61:135–141.
13. Kim KB, Suh YJ, Ahn GH, Chun SW, Cho WI, Kim SN, Lee JH. A clinical review of 81 cases of total thyroidectomy. J Korean Surg Soc. 1997; 52:13–20.
14. Polyzos SA, Anastasilakis AD. Clinical complications following thyroid fine-needle biopsy: a systematic review. Clin Endocrinol (Oxf). 2009; 71:157–165.
Article
15. Christou N, Mathonnet M. Complications after total thyroidectomy. J Visc Surg. 2013; 150:249–256.
Article
16. American Thyroid Association Guidelines Task Force. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009; 19:565–612.
Article
19. Scottish Intercollegiate Guidelines Network. Long term follow up of survivors of childhood cancer [Internet]. Edinburgh: Scottish Intercollegiate Guidelines Network;2013. cited 2015 Apr 9. Available from:
http://www.sign.ac.uk.
20. British Thyroid Association. Royal College of Physicians of London. Guidelines for the management of thyroid cancer. 2nd ed. London: Royal College of Physicians;2007.
21. The Korean Academy of Family Medicine. Periodic health exa-mination and prevention guidelines for Koreans. 3rd ed. Seoul: Gukjin P&D;2009.
22. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. U.S. Preventive Services Task Force. Update on the methods of the U.S. Preventive Services Task Force insufficient evidence. Ann Intern Med. 2009; 150:199–205.
Article
23. Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R. Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol. 2011; 18:5875–5883.